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Human Cytomegalovirus Infection Increases Both
Antibody- and Non–Antibody-Dependent Cellular
Reactivity by Natural Killer Cells
Clive M. Michelo, PhD,1 Bram van Cranenbroek, BSc,1 Peran Touw, BSc,1 Frans H. J. Claas, PhD,2
Arnold van der Meer, PhD,1 Irma Joosten, DVM, PhD1
Background. Antibody-mediated rejection in solid organ transplantation is an important immunological barrier to successful
long-term graft survival. Next to complement activation, natural killer (NK) cells have been implicated in the process. Human cytomeg-
alovirus (CMV), independently associated with decreased graft survival, has a strong imprint on the immune response. Here, we
assessed the effect of CMV status on alloreactive NK cell reactivity.Methods.We compared antibody-mediated NK cell cytolytic
activity (CD107a expression) and IFNγ production between healthy CMV-seropositive (n = 8) and CMV-seronegative (n = 11) individ-
uals, in cocultures of NK cells with anti-HLA class I or rituximab (control) antibody-coated Raji cells.Results. First, we showed that
within the NKG2C+ NK cells, it is specifically the NKG2C+/A− subset that is enriched in CMV+ individuals. We then observed that in
particular the NK cell antibody-dependent cell mediated cytotoxicity (ADCC), but also non-ADCC alloreactivity toward HLA-positive
target cells was increased in CMV+ individuals as compared to CMV− ones. This enhanced ADCC as well as non-ADCC NK cell
reactivity in CMV+ individuals was particularly characterized by a significantly higher number of ILT2+ and NKG2C+ NK cells that
possessed cytolytic activity and/or produced IFNγ in response to HLA-positive target cells.Conclusions.With regard to organ
transplantation, these data suggest that CMV infection enhances NK cell alloreactivity, which may pose an additional adverse
effect on graft survival, especially in the presence of donor specific antibodies.
(Transplantation Direct 2017;3: e335; doi: 10.1097/TXD.0000000000000750. Published online 20 November, 2017.)
Solid-organ transplant rejection occurs when the graft isadversely affected by the recipient’s immune system.De-
spite the use of potent immunosuppressive drugs, the occur-
rence of chronic rejection, and consequently graft rejection
is still a serious problem.
Several factors have been highlighted as risks for solid or-
gan rejection; one being the occurrence of cytomegalovirus
(CMV) infection. Infection with the human CMV is an im-
portant cause of morbidity andmortality in solid organ recip-
ients and was implicated in the pathogenesis of allograft
rejection.1-4 However, how CMV mediates this rejection is
still unclear.
One of the key cells in the immune response to CMVinfec-
tion is the natural killer (NK) cell. NK cells have been shown
to proliferate and increase their reactivity in response to
CMV viremia.5,6 Over time, CMV infection induces a stable
imprint in the NK cell receptor repertoire, involving the activat-
ing lectin-like receptor NKG2C and killer immunoglobulin-like
receptors (KIRs).7-9 The resultant CMV-specific NK cells
have a differentiated mature phenotype exhibiting specialized
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antibody-dependent cell cytotoxicity (ADCC) and show-
ing poor interferon gamma (IFNγ) production to cytokine
stimulation.7,8,10,11
Antibody-mediated rejection (AMR) poses a significant
risk for long-term graft survival of solid organ transplantation
with hardly any effective immunosuppressive treatment.12-15
Compared with T cell–mediated rejection, AMR poses a
greater risk to long-term graft survival.16,17 The antibodies in-
volved are mostly directed against human leukocyte antigen
(HLA) class I and II antigens. AMR can be mediated via the
activation of the classical complement pathway or via comple-
ment independent ADCC.14,18 Although the complement path-
way has been highlighted as the main cause of acute AMR,
several studies have shown that NK cells have a significant
role in complement-independent and chronicAMR.13,17,19,20
In kidney transplantation, ADCC pathways involving NK
cells have been highlighted to be active during AMRand con-
sistently suggestmediationofallograft injury ina complement
independent manner.21,22
These observations led us to investigate in vitro the effect
of CMV infection on NK cell antibody-mediated reactivity.
We isolated NK cells from CMV+ and CMV− healthy indi-
viduals and tested them for in vitro reactivity to anti-HLA
antibody-coated allogeneic target cells. Our results show that
NK cells derived from CMV+ individuals have an increased
reactivity to allogeneic target cells, both in the absence and
presence of target cell-specific antibodies compared to NK
cells from CMV− individuals.
MATERIALS AND METHODS
NK Cell Isolation and Enrichment
NK cells were isolated from buffy coats of 19 healthy
blood donors purchased from Sanquin Blood Supply Founda-
tion, region Southeast, Nijmegen, The Netherlands. Buffy coats
were obtained upon written consent from the donor for scien-
tific use, and according to Dutch law. Gradient centrifugation
using Lymphoprep (Nycomed Pharma, Norway) was used to
isolate peripheral blood mononuclear cells (PBMCs). NK cells
were isolated using theMACSNKcell isolation kit according
to the manufacturer’s instructions (Miltenyi Biotec, Bergisch
Gladbach, Germany). NK cell purity was measured by flow
cytometry; NK cells were defined as CD56+/CD3− lympho-
cytes and purity ranged between 85% and 95%. NK cells
were subsequently frozen at −80°C for later use.
CMV Testing
Of all voluntary blood donors, a serum aliquot was col-
lected for CMV testing. Detection of anti-CMV IgG antibod-
ies was performed using a commercially available ELISA
immunoassay (Serion, Wurzburg, Germany), according to
the manufacturer’s instructions.
Raji Cell Line
The Raji cell line was cultured in RPMI 1640 medium
(Gibco, Life Technologies, Bleiswijk, Netherlands) supple-
mented with Gibco penicillin (100 U/mL), streptomycin
(100 μg/mL), glutamax (2 mM) pyruvate (1 mM) and 10%
Greiner Bio-one fetal calf serum (FCS) (Greiner Bio-one,
Frickenhausen, Germany). Cultures were maintained at 37°C,
95% humidity and 5% CO2. DNA from Raji cells was
isolated using a Qiagen DNA isolation kit (Qiagen Benelux
B.V., Venlo, TheNetherlands) according to themanufacturer’s
instructions. HLA genotyping of the cell line was performed
by PCR-SSOP, using Luminex technology (Sanbio, Uden,
The Netherlands). HLA class I typing of the Raji cells used
was confirmed as HLA: A*03, B*15, C*03, C*04.
NK Cell Antibody-Dependent Reactivity and Flow
Cytometric Analysis
Raji cells were either left untouched or precoated with
human anti-HLA-A3 IgG antibody, an anti–HLA-A3 human
IgM antibody (as negative control)23 and the CD20 antibody
rituximab (RTX) (Genentech, San Francisco, CA) (positive
control). Rituximab and anti–HLA-A3 IgM coating of Raji
cells was done at a concentration of 10 μg/mL, and the
anti–HLA-A3 IgG antibody was used at 5 μg/mL. The coat-
ing was done in culture medium consisting of RPMI 1640
medium supplemented with Gibco penicillin (100 U/mL),
streptomycin (100 μg/mL), glutamax (2 mM), pyruvate
(1 mM), and 10% Greiner Bio-one fetal calf serum (FCS) at
room temperature for 30 minutes, after which the cells were
washed and co-cultured with NK cells. Approximately 2 
105 NK cells were cocultured with the same number of Raji
cells; 1:1 ET ratio in 200 μL culture medium. NK cells alone
and NK cells cultured with uncoated Raji cells were used as
additional controls. To measure NK cell cytolytic reactivity,
the coculture was performed in 200 μL of culture medium
in the presence of anti-CD107a BV510 (clone H4A3,
Biolegend) antibody, 10 μg/mL brefeldin A and 10 μg/mL
monensin. The cells were cultured for 4 hrs at 37 °C, 95%
humidity and 5% CO2. After incubation, the cells were
washed once and stained for NK cell surface markers with
conjugated mAbs for 15 minutes: CD159c PE (NKG2C
clone 134522) (R&D, Abingdon, United Kingdom), CD85j
PC5.5 (clone HPF1.4), CD158b1b2/j PC7 (clone GL183),
CD158e1e2 APC (clone Z27.3.7), CD158ah APC AF700
(EB6.B.3.1.1), CD3 APC AF750 (clone UCHT1), CD56
ECD (clone N901), and CD159a pacific blue(NKG2A)
(clone Z199.1.10), all from Beckman Coulter (Woerden,
The Netherlands). The cells were then washed and fixed with
fixation/permeabilization buffer (BD Biosciences) and stained
for IFNγ FITC (cat:554551, BD Pharmingen) for 30 minutes
at 4 °C in 1 permeabilization buffer (eBioscience Vienna,
Austria). Samples were measured on the Beckman Coulter
Navios instrumentation, and the data were analyzed using
the Beckman Coulter Kaluza v1.2 software. Marker analysis
was done on the CD56+/CD3− NK cell populations gated
from the FSc vs SSc plot (for gating strategy, see figures). NK
cell marker gates were set based on isotype controls and/or
positive/negative staining. We did not include a FSC-H/FSC-A
doublet discrimination, which is a limitation to the experi-
mental design.
Statistical Analysis
Statistical analyses were performed using GraphPad Prism.
Data are represented as sample median values. Statistical
differences were calculated using the nonparametric Mann
Whitney test for unpaired analysis, and the nonparametric
Wilcoxon matched-pair signed rank test. Differences were
considered significant at P < 0.05(*), P < 0.01(**) or
P < 0.001(***).
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RESULTS
Enhanced Reactivity of NK Cells
From CMV+ Individuals
CD56dimNK cells fromCMV+ (n = 8) and CMV− (n = 11)
healthy individuals were evaluated for selected NK cell recep-
tor expression, that is, NKG2C, NKG2A, ILT2, KIR2DL1/
S1, KIR2DL2/L3/S2, and KIR3DL1/S, using flow cytometry
(Figure 1A). Previously, selective expansion of NKG2C+ NK
cells was highlighted as a hallmark of CMV infection.8,9,24-27
Also here, comparing CMV+ and CMV− individuals, we
found higher percentages of this subset upon CMV infection
(Figure 1B) (median: 19% versus 7%, respectively; P = 0.009).
Notably, a more detailed analysis revealed that the increase in
NKG2C-positive cells in the CMV+ individuals could be
ascribed to a shift in the NKG2C+/NKG2A- NK cell subset
(Figure 1C). Additional analysis of the NKG2C+ population
in CMV+ individuals revealed that the NKG2C/ILT2 double
positive subset was expanded compared to CMV− individuals
(NKG2C+/ILT2+; median 12% vs 4%, P = 0.013) (Figure 1D).
A similar analysis was done on CD56bright NK cells (Figure S1,
SDC, http://links.lww.com/TXD/A55). This revealed that the
NKG2C skew in CMV+ individuals was a particular
characteristic of the CD56dim population. In addition, the
CD56bright NK cell compartment in CMV+ individuals
comprised more ILT2+ cells and less NKG2C–/A+ NK cells
than found in CMV− individuals.
Because the NKG2C+NK cells resulting from CMV infec-
tion have been shown to exhibit a differentiated mature phe-
notype and enhanced antibody-dependent reactivity,7,8,10,11
we were interested to see how they behaved in the presence
of a target cell coated with anti-HLA antibodies. We there-
fore evaluated the reactivity of NK cells from CMV+ and
CMV− individuals to anti–HLA-A3 antibody-coated Raji
cells. An IgM anti–HLA-A3 and RTX (anti-CD20 mAb)
were used as negative and positive control, respectively. IFNγ
production and CD107a expression were measured after
stimulation (Figure 2). In CMV+ individuals, baseline (non-
ADCC) reactivity against uncoated Raji cells or anti–HLA-
A3 IgM-coated Raji cells was higher as compared with
CMV− individuals (median %, CD107a-positive cells: CMV
+, 29% (uncoated); 30% (IgM) vs CMV−, 17% (uncoated);
16% (IgM), P= 0.03; 0.02, respectively), and there was a
trend toward higher IFNγ expression (median % positive
cells: CMV+, 8%; 7% vs CMV−, 6%; 5%, P = 0.07; 0.06,
respectively). The presence of anti–HLA-A3 IgG antibody, as
well as RTX strongly increased the reactivity in both CMV+
and CMV− individuals, while still revealing a higher level of
reactivity in the CMV+ group for both CD107a and IFNγ
expression (median % CD107a for anti–HLA-A3 IgG, CMV
+ vs CMV−, 45% vs 36%; P = 0.01; median % IFNγ CMV
+ vs CMV−, 14% vs 10%; P = 0.02) (median % CD107a for
RTX: CMV+ vs CMV−, 48% vs 36%, P = 0.05; median %
IFNγ CMV+ vs CMV−, 14% vs 10%, P = 0.02) (Figure 2).
We thus observed that NK cell reactivity toward Raji cells
was augmented inCMV+NKcells comparedwithCMV−NK
cells, and this was particularly so for the antibody-dependent
cell reactivity in the presence of target cell-specific antibodies,
that is, both anti–HLA-A3 IgG as well as RTX.
NK Cell Receptor Expression on Reactive NK Cells
From CMV+ and CMV—Individuals
Having observed an overall higher reactivity fromNKcells
derived from CMV+ individuals, and knowing that NK cell
function is closely related to surface receptor repertoire,28,29
we set out to further characterize the reactive (CD107a+ or
FIGURE 1. Flow cytometric analysis of NK receptor expression on isolated NK cells from CMV+ (n = 8) and CMV− (n = 11) individuals. A, Gat-
ing strategy and example dot plots from a single representative CMV+ individual. CD56+/CD3− cells NK cells gated from the FSc/SSc plot,
were further subdivided into CD56dim and `CD56bright cells. Both subsets were further analyzed for the expression of selected markers (for data
on CD56bright NK cells see Figure S1, SDC, http://links.lww.com/TXD/A55). B-C, Scatter plots showing cumulative data for the percentage of
NK receptor-positive/negative cells (as indicated on the x-axis) within the CD56dim NK population in CMV+ and CMV− individuals; the solid lines
indicate median value. Statistical differences were calculated using the nonparametric Mann-Whitney test and differences were considered
significant at *P < 0.05, **P < 0.01.
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IFNγ+) NK cells for the expression of NKG2C,NKG2A, ILT2,
KIR2DL1/S1, KIR2DL2/L3/S2, andKIR3DL1/S1 (Figure 3). In
CMV+ individuals, regardless of the stimulus used, the
distribution of the NK subsets in the reactive population was
comparable, that is, the phenotype of NK cells reactive to
uncoated Raji cells was similar to that of NK cells reacting to
(control or test) antibody-coated Raji cells. Also within the
CMV− individuals each of the stimuli tested resulted in a
similar NK subset division. However, there were differences in
subset distribution between CMV+ and CMV− individuals.
NK cells from CMV+ individuals as compared with CMV−
individuals revealed a higher percentage of NKG2C+ NK cells
in the CD107a+ reactive cells (P < 0.05 for all conditions),
and IFNγ+ cells (trend: P = 0.06 for the anti–HLA-A3 IgG
condition) (Figure 3). Also, for the anti–HLA-A3 IgM and
HLA-A3 IgG antibody-coated Raji cell conditions, the
percentage of ILT2+ NK cells among the reactive IFNγ+ cells
was higher (median, 92% vs 85%; P = 0.02; and median,
89% vs 75%; P = 0.01, respectively).
We further profiled NKG2C+ NK cells and their counter-
part NKG2A+NK cells for the expression of selected NK cell
receptors (KIR2DL1/S1, KIR2DL2/L3/S2, KIR3DL1/S1,
ILT2, NKG2C (for NKG2A+ cells only), and NKG2A (for
NKG2C+ cells only) (Figure S2, SDC, http://links.lww.com/
TXD/A55). In isolatedNK cells, cultured for 4 hrs in medium
alone, we observed an expansion of NKG2C+ cells expressing
ILT2 in CMV+ as compared with CMV− individuals, and a
relative loss ofNKG2C+ cells that also expressNKG2A+. This
difference between CMV+ and CMV− individuals was not
observed in the reactive population (IFNγ+ or CD107a+)
upon coculture with anti–HLA-A3 IgG antibody-coated Raji
cells. In CMV+ individuals, NKG2A+ cells expressed more
NKG2C upon 4 hrs culture in medium alone, also observed
in the reactive populations upon coculture with anti–HLA-A3
IgG antibody-coated Raji cells (trend in IFNγ-positive cells).
In the latter condition, also a higher level of ILT2+NKG2A+ cells
was observed in the CMV+ compared with CMV− individuals.
Preferential Use of NKG2C+ and ILT2+ NK Cells in
Reactive CMV+ NK Cells
Given the observed enhanced NK cell reactivity in CMV-
positive individuals and the increased percentage of
NKG2C+ and ILT2+ NK cells in the reactive population,
we wished to determine the actual contribution of these 2
populations to the observed NK cell reactivity. Hereby, we
focused our analysis on the experiments with HLA-A3 spe-
cific IgG-coated Raji cells. From a fixed number of NK cells,
we calculated the proportions of reactive (IFNγ+ and/or
CD107a+) NKG2C and ILT2-positive and -negative cells
(Figure 4). The proportion of NKG2C+/IFNγ+ NK cells in
FIGURE 2. Percentage of IFNγ-producing and degranulating (CD107a expressing) NK cells in response to allogeneic Raji cells coated with
(anti-HLA) antibodies in CMV+ (n = 8) and CMV− (n = 11) individuals. 2  105 NK cells from CMV+ and CMV− individuals were cultured for
4 hours, either alone, or with uncoated or anti–HLA-A3 IgG, anti–HLA-A3 IgM (negative control) or RTX (positive control) antibody-coated Raji
cells. Coculture was done at a 1:1 ratio for 4 hours in 200-μL medium, in the presence of anti-CD107a BV510 antibody, 10 μg/mL brefeldin A
and 10 μg/mL monensin. After incubation, the cells were additionally stained for IFNγ and selected NK cell markers and analysed using flow
cytometry. The upper left panel shows the gating strategy, whereby NK cells were gated out based on the CD56/CD3 plot, using software set-
tings that included the co-cultured Raji cells (indicated by arrow). The upper right panel shows a representative example of a CMV+ individual.
The lower panel shows scatter plots of cumulative data on IFNγ expression (left panel) and CD107a expression (right panel); the solid line in-
dicates median value. Statistical analysis was done using the nonparametric Mann-Whitney test for unpaired analysis, and the nonparametric
Wilcoxon matched-pair signed rank test where appropriate and differences were considered significant at *P < 0.05, **P < 0.01, or
***P < 0.001.
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CMV+ individuals was significantly larger than in CMV−
individuals (median, 7% vs 3% of total NK cells, P = 0.005);
this also held true for NKG2C+/CD107a+ cells (14% vs 5%
of total NK cells, P = 0.001). A similar trend, albeit not
significant, was observed for the NKG2C- cells (CMV+ vs
CMV− median NKG2C-/IFNγ+ cells, 8% vs 6% of total NK
cells P = 0.236; NKG2C−/CD107a+ cells: 32% vs 25% of
total NK cells; P = 0.17). Interestingly, in both CMV+ and
CMV− individuals, there were comparatively more reactive
NKG2C− than NKG2C+ cells. For the ILT2+ population, the
proportion of ILT2+/IFNγ+ NK cells was also significantly
higher in CMV+ individuals as compared with CMV−
individuals (11% vs 7% of total NK cells; P = 0.001). Also, the
ILT2+/CD107a+ population was significantly higher in CMV+
individuals (38% vs 27% of total NK cells; P = 0.026). The
reactive ILT2− population did not show a significant difference
between CMV+ and CMV− individuals. Thus, CMV infection
resulted in an increased proportion of both NKG2C+ and
NKG2C− NK cells. Most reactive NK cells were ILT2-positive,
particularly in CMV+ individuals.
DISCUSSION
A role for CMVin the pathogenesis of solid organ allograft
rejection has long been suggested.3,4,30,31 However, how
CMV mediates this process is still unclear. In this study, we
examined whether CMV infection and associated changes
in NK cell phenotype and function might affect the
antibody-dependent cellular reactivity of NK cells. This might
be one of the ways in which CMV is involved in AMR of solid
organs. AMRposes a risk for long-term graft survival in kidney
transplantation.12-14,16 AMRcan bemediated via the activation
of the classical complementary pathway or via the complement
independent ADCC.14 In kidney transplantation, the comple-
ment independent pathway involving NK cell ADCC activity
FIGURE 3. Phenotypic characteristics of the reactive NK cell population (CD107a+ or IFNγ+) in CMV+ (n = 8) and CMV− (n = 11) individuals
upon coculture with uncoated or (allo) antibody-coated Raji cells (from the experiments in Figure 2). The expression of selected NK cells
markers (NKG2C/A, ILT2, KIR2DL1/S1, KIR2DL2/L3/S2, and KIR3DL1/S1) was examined on IFNγ+ and CD107a+ cells. Scatter plots of cu-
mulative data on% positive cells are shown; the solid line indicates median value. Statistical differences were calculated using the nonparamet-
ric Mann-Whitney test and differences were considered significant at *P < 0.05, **P < 0.01.
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and donor-specific antibodies has been highlighted as a major
contributor to graft injury.13,19-22
CMV infection affects both phenotype and function of a
subset of NK cells. Comparing NK cells from CMV+ and
CMV− individuals, and in line with data from others, we
show that the changes induced by CMV infection on NK cell
phenotype results in a phenotypically more mature NK cell
population, exhibiting a relative increase in NKG2C+ cells
while maintaining a seemingly stable NKG2A, KIR and
ILT2 expression.7,8,24,32 The increase in NKG2C+ NK cells
varies between individuals,9,24,32 and is accompanied by
functional changes in this cell subset, such as increased ADCC
activity and a dampened response to exogenous cyto-
kines.7,8,10,11 However, most studies so far compared the re-
activity of NKG2C+NK cells with that of either NKG2C− or
NKG2A+NK cells, from the same CMV+ individual. In con-
trast, using a different approach, we compared phenotype
and function of the total NK cell population and subsets be-
tween CMV+ and CMV− individuals. Our results show that
CMV infection leads to an increase in NK cell mediated di-
rect (non-ADCC) reactivity toward allogeneic target cells.
This reactivity was further augmented in the presence of tar-
get cell-specific antibodies, and was as such also observed in
the presence of anti-HLA antibodies. Significantly higher
proportions of reactive NKG2C+ and ILT2+ NK cells were
associated with the enhanced cytotoxicity and IFNγ produc-
tion by NK cells found in CMV+ individuals. Indeed, in all
stimulatory conditions both the ADCC or non-ADCC
alloreactive NK cells (CD107a+) from CMV+ individuals
contained a higher percentage of NKG2C+ cells as compared
with CMV− individuals, in line with the percentage of NK
cells initially expressing NKG2C (Figure 1). A similar phenom-
enon was observed for ILT2 expression on IFNγ-producing
NK cells, that is, higher percentages of ILT2+ reactive
NK cells in CMV+ individuals. Notably, the percentage
of ILT2-positive cells in the reactive population was much
higher than in the starting population in both CMV+ and
CMV− individuals. ILT2 is an inhibitory receptor
expressed by NK cells and targeted by UL18, a CMV
homolog for the MHC class I molecules.33 CMV infected
cells down regulate MHC class I molecules to evade T cells
and upregulate HLA-E and UL-18 to inhibit NK cells via
NKG2A and ILT2 receptors, respectively.34-36 In CMVinfec-
tion, ILT2 expression on lymphocytes was found to be signif-
icantly increased.32,37 The mechanism driving this increased
expression is not clear but it might be that expansion of
ILT2+ cells is driven by an upregulated UL18 expression
or, alternatively, this may serve as a protective mechanism
to suppress autoimmunity in the face of chronic antigen stim-
ulation.34 However, our study shows that the ILT2+ NK cells
are in fact potent effector cells. The high proportions of reac-
tive ILT2+ NK cells suggest that this receptor plays a major
role in the response to the allogeneic Raji cells. NK cells
derived from CMV+ individuals were more reactive than
those of CMV− individuals, which was observed both for
NKG2C+ cells, and to a lesser extent, NKG2C− NK cells
(trend). This is in line with the study by Bèziat et al,7 who
showed that CMV+ individuals that lacked the NKG2C
expanded population exhibited similar functional character-
istics in other NK cell phenotypes.
Next to the antibody-dependent cellular reactivity induced
by the anti-HLA antibody, the baseline cytotoxic reactivity
against the Raji cells was also higher in CMV+ individuals
compared to CMV− individuals. The exact nature of this re-
activity could not be defined, but interactions of ligands on
the target cell with either NK cell inhibitory receptors as is
FIGURE 4. Contribution of the NKG2C+ and ILT2+ populations to overall NK cell reactivity. Data are derived from the experiments in Figure 2.
From total NK cells, the proportions of reactive (IFNγ+ and/or CD107a+) NKG2C and ILT2-positive and -negative cells were calculated and
compared between CMV+ and CMV− individuals. Statistical differences were calculated using the nonparametric Mann-Whitney test and dif-
ferences were considered significant at *P < 0.05, **P < 0.01.
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the case in amissing-self alloresponse, and/orNK cell activating
receptorsmay play a role. Brodin et al29 showed thatNK cell re-
activity can be quantitatively fine-tuned by external NK cell li-
gands, the so-called rheostat model of NK cell education.29
Considering that CMV induces a mature NK cell phenotype,
which theoretically could have undergone extensive functional
education,8 thismay have resulted in different activation thresh-
old levels.
In summary, CMVresults in a higher overall NK cell reactiv-
ity, which augments antibody-dependent reactivity, including
reactivity to anti–HLA-specific antibodies. These data suggest
that patients who have donor-specific antibodies may be at an
additional risk to develop AMR when they are CMV-positive.
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